Gene therapy for children with AADC deficiency

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the safety and efficacy of a gene therapy called AAV2-hAADC in pediatric patients diagnosed with aromatic L-amino acid decarboxylase (AADC) deficiency. The therapy is delivered to specific brain regions to restore AADC function, which is crucial for dopamine production. The study will monitor adverse events, clinical responses, and changes in motor function through various assessments, including MRI and clinical laboratory tests. It is designed as a single-stage, adaptive, open-label, dose escalation study to gather preliminary data on treatment effects.

Why it matters

Who can join: the full rules

Inclusion Criteria

1. Definite diagnosis of AADC deficiency, confirmed by at least two of the following three criteria: (1) CSF neurotransmitter profile demonstrating reduced HVA and 5-HIAA, and elevated 3-OMD concentrations; (2) Plasma AADC activity less than or equal to 5 pmol/min/mL; (3) Molecular genetic confirmation of homozygous or compound heterozygous mutations in DDC.
2. Age 24 months and older.
3. Failed to derive adequate benefit from standard medical therapy (dopamine agonists, monoamine oxidase inhibitor, pyridoxine or related form of Vitamin B6), as judged by presence of residual oculugyric crises and developmental delay.
4. Documented history of motor developmental delay, with inability to walk independently without support by age 18 months.
5. Cranium sufficiently developed, with sutures closed, to enable surgical placement of SmartFrame® system on the head for MRI-guided stereotactic targeting.
6. Brain MRI does not show any conditions or malformations that are clinically significant with respect to risks for stereotactic brain surgery.
7. Parent(s)/legal guardian(s) of the subject must agree to comply with the requirements of the study, including the need for frequent and prolonged follow-up.
8. Both parents (or legal guardians) must give their consent for their child's participation in the study parents unless (i.) one parent is deceased, unknown or incompetent; (ii.) one parent is not reasonably available; or (iii.) one parent has responsibility for the care and custody of the child (if consistent with state law).
9. Baseline hematology, chemistry, and coagulation values within the normal pediatric laboratory value ranges, unless in the Investigator's judgment, the out-of-range values are not clinically significant with respect to subject's suitability for surgery.

Exclusion Criteria

1. Intracranial neoplasm or any structural brain abnormality or lesion (e.g., severe brain atrophy, white matter degenerative changes), which, in the opinion of the study investigators, would confer excessive risk and/or inadequate potential for benefit.
2. Presence of other significant medical or neurological conditions that would create an unacceptable operative or anesthetic risk (including congenital heart disease, respiratory disease with home oxygen requirement, history of serious anesthesia complications during previous elective procedures, history of cardiorespiratory arrest), liver or renal failure, malignancy, or HIV positive.
3. Previous stereotactic neurosurgery.
4. Coagulopathy, or need for ongoing anticoagulant therapy.
5. Contraindication to sedation during surgery or imaging studies (SPECT, PET or MRI).
6. Receipt of any investigational agent within 60 days prior to Baseline and during study participation.
7. Evidence of clinically active infection with adenovirus or herpes virus on physical examination.

Where it's running

• University of California San Francisco, Benioff Children's Hospital
  San Francisco, California, United States Recruiting
• Nationwide Children's Hospital
  Columbus, Ohio, United States Recruiting
• The Ohio State University Medical Center
  Columbus, Ohio, United States Recruiting

Study contacts

• Study coordinator: Andrea Davis, MS
• Email: andrea.davis@osumc.edu
• Phone: 614-688-6412

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Arthrocentesis with ACL Reconstruction for Acute ACL Tears

  This trial tests whether draining the knee before and after ACL reconstruction helps reduce inflammation, prevent muscle loss, and speed recovery in people with a recent ACL tear.

  Recruiting at 2 sites Ohio State University · Columbus, Ohio and 1 other locations · NCT07929922

• Restoring Emotional Balance With Ketones for Women After Birth

  This study tests whether taking a ketone supplement plus group cognitive-behavioral counseling and guided exercise can help women within 12 months after birth who have postpartum depression feel better.

  Recruiting Ohio State University · Columbus, Ohio · NCT07919392

• Do dual-focus multifocal contact lenses improve hand-eye coordination and sports vision compared with your usual lenses

  This study tests whether wearing dual-focus multifocal contact lenses improves hand-eye coordination and sports vision in adults who play baseball or softball and normally wear contact lenses.

  Recruiting Ohio State University · Columbus, Ohio · NCT07840209

• New Generation Therapies for Suicide: Refining Brief Cognitive Behavioral Therapy

  This study tests different sequences and doses of Brief Cognitive Behavioral Therapy to see if it better reduces suicide risk in adults with recent suicidal thoughts or behavior.

  Recruiting Ohio State University · Columbus, Ohio · NCT07818889

• Anxiety Skills Study: See if video skill training plus therapy helps people with anxiety

  This study tests whether a brief video-based skill training can help people with anxiety as well as four therapy sessions, and how durable the effects are over a year.

  Recruiting Ohio State University · Columbus, Ohio · NCT07774481

• Restrained vs Gripping Wrist Restraints for Cesarean Delivery

  This study tests whether a soft wrist-level gripping restraint reduces anxiety for adults having an elective cesarean delivery under spinal or combined spinal-epidural anesthesia.

  Recruiting Ohio State University · Columbus, Ohio · NCT07772219

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.